The protein corona at the nano-bio interface: the need for standardized methodology and opportunities for neurodegenerative disease intervention. [PDF]
Shitaye G +11 more
europepmc +1 more source
hERG1 channels and potential therapeutics for long QT syndrome
Abstract figure legend Prolonged QT results from hERG1 channel dysfunction. (A) Physiological anterograde trafficking of hERG1 channels to the plasma membrane, leading to a normal electrocardiogram. (B) Prolonged QT results from the presence of fewer hERG1 channels on the plasma membrane due to decreased anterograde trafficking or reduced function due ...
Elizabeth H. Schneider +3 more
wiley +1 more source
The OCEANIC trial journey: from failure to breakthrough? [PDF]
Caso V, Ten Cate H, van Gelder IC.
europepmc +1 more source
Complementary targeted constructs factor XI/XIa inhibition. [PDF]
Becker RC.
europepmc +1 more source
Inhibitory Activity of Red Panda Islet Amyloid Polypeptide on Human IAPP Aggregation
The figure shows the comparison of (a) human islet amyloid polypeptide (hIAPP) self‐assembling into a fibril structure and (b) a model of hIAPP self‐assembling in the presence of red panda islet amyloid polypeptide (IAPP). The figure was produced from PDB file 6Y1A using Swiss PDB viewer software.
Lauren Phillips +5 more
wiley +1 more source
Factor XI and XIa Inhibitors: A State-of-the-Art Review Across Clinical Indications. [PDF]
Oikonomou E, Goldin M, Spyropoulos AC.
europepmc +1 more source
Objective Nerve growth factor (NGF), a key mediator of pain, is increased in osteoarthritic (OA) joints. Antibodies against NGF show analgesic effects in painful knee OA, but clinical development was stopped because of side effects in the joints. Knowledge about the biologic effects of NGF on joint tissues is limited. Therefore, we explored the effects
Alia M. Obeidat +14 more
wiley +1 more source
Exercise preconditioning reduces the electrostimulation-induced incidence of arrhythmias in exhausted rats by regulating the CaMKⅡ-RyR2 signaling pathway. [PDF]
Wang Y +8 more
europepmc +1 more source
New therapeutic options for metabolic‐associated steatotic liver disease
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley +1 more source

